Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT06770543

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Led by Novartis Pharmaceuticals · Updated on 2025-12-22

1500

Participants Needed

4

Research Sites

281 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This non-interventional study is a mandatory regular Post Marketing Surveillance(rPMS) granted by the Korean health authorities, and is conducted to assess the effectiveness and safety of Leqvio® Pre-filled Syringe(inclisiran sodium) in routine clinical practice for the approved indications (primary hypercholesterolemia or mixed dyslipidemia).

CONDITIONS

Official Title

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older with hypercholesterolemia or mixed dyslipidemia prescribed Leqvio Pre-filled Syringe (inclisiran sodium) according to approved product information
  • Patients unable to reach LDL-C target with maximum tolerated dose of statin, or with statin intolerance
  • Patients who have provided informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Contraindications as per domestic prescribing information for Leqvio
  • Patients currently participating in clinical trials of other investigational drugs
  • Patients who do not provide consent to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Novartis Investigative Site

Yangsan, Gyeongsangnam-do, South Korea, 50612

Actively Recruiting

2

Novartis Investigative Site

Busan, South Korea, 49241

Actively Recruiting

3

Novartis Investigative Site

Seoul, South Korea, 04763

Actively Recruiting

4

Novartis Investigative Site

Taegu, South Korea, 41944

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here